Background Human papillomavirus (HPV) vaccines were designed to prevent cervical
cancer in women and their provision remains a major public health need. However, HPV is …

Objectives: HPV vaccine acceptability was examined as part of a cohort study of HPV
infection among adult males. Methods: Between July 2004 and June 2007, 445 adult males …

Cervical cancer incidence and mortality have decreased in high-income countries, but low-
and middle-income countries continue to bear a significant burden from the disease. Human …

Infection with genital human papillomavirus (HPV) may cause anogenital cancers,
oropharyngeal cancers, anogenital warts, and respiratory papillomas. Two prophylactic …

Human papillomavirus (HPV) is an extremely prevalent sexually transmitted infection that is
typically acquired soon after onset of sexual activity. The burden of HPV-related malignant …

It has been clearly established that sexually transmitted human papillomavirus (HPV)
infections are the major cause of genital warts and cervical cancer and are a contributing …

Background: Despite screening, cervical cancer (CC) remains a serious health care
problem. Because human papillomavirus (HPV) is the necessary cause of CC, the …

Background Human papillomavirus (HPV) vaccination is safe and effective in preventing
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …

Summary of the Clinical Problem Human papillomavirus is a highly prevalent sexually
transmitted infection. Prior to vaccination programs, 1 large study of US female individuals …

Routine vaccination programs have had a substantial impact on reducing the prevalence of
a variety of infectious diseases. In light of the fact that human papillomavirus (HPV) is a …